The Current Ratio as of November 2024 (TTM) for Indivior PLC (INVVY) is 0.83

According to Indivior PLC’s latest financial reports and current stock price. The company's current Current Ratio is 0.83. This represents a change of -7.11% compared to the average of 0.89 of the last 4 quarters.

Indivior PLC (INVVY) Historical Current Ratio (quarterly & annually)

How has INVVY Current Ratio performed in the past?

The mean historical Current Ratio of Indivior PLC over the last ten years is 1.48. The current 0.83 Current Ratio has changed 5.51% with respect to the historical average. Over the past ten years (40 quarters), INVVY's Current Ratio was at its highest in in the December 2021 quarter at 1.80. The Current Ratio was at its lowest in in the September 2024 quarter at 0.83.

Indivior PLC (INVVY) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Indivior PLC Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Indivior PLC (INVVY) Average Current Ratio

How has INVVY Current Ratio performed in the past?

The current Current Ratio of Indivior PLC (INVVY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Indivior PLC (INVVY) Current Ratio vs. Peers

How is INVVY’s Current Ratio compared to its peers?

Indivior PLC’s Current Ratio is less than Orexo AB (publ) (1.70), less than Genomma Lab Internacional, S.A.B. de C.V. (1.81), less than Hypera S.A. (1.89), greater than Sumitomo Pharma Co., Ltd. (0.65), less than Elanco Animal Health Incorporated (2.93), less than SIGA Technologies, Inc. (8.25), less than Esperion Therapeutics, Inc. (1.97), less than Catalent, Inc. (2.52), less than Neurocrine Biosciences, Inc. (4.37), less than Amphastar Pharmaceuticals, Inc. (3.52), less than Collegium Pharmaceutical, Inc. (1.11), less than Ironwood Pharmaceuticals, Inc. (3.92), less than ANI Pharmaceuticals, Inc. (3.97), less than Alpha Teknova, Inc. (4.76), less than Guardion Health Sciences, Inc. (16.67), less than Lifecore Biomedical, Inc. (1.83), less than Organogenesis Holdings Inc. (2.73), less than Petros Pharmaceuticals, Inc. (1.40), less than Pacira BioSciences, Inc. (6.82), less than Intra-Cellular Therapies, Inc. (7.66), less than Alkermes plc (3.45), less than Eagle Pharmaceuticals, Inc. (1.70),

Build a custom stock screener for Indivior PLC (INVVY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Indivior PLC using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Indivior PLC (INVVY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Indivior PLC or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.